Characterization of muscarinic receptors: type M2 (subtype B) on neuro-2A neuroblastoma cells.
The binding of the nonselective muscarinic antagonist, [3H]N-methylscopolamine (NMS) to a mouse neuroblastoma cell line (Neuro-2A) and its coupling to the inhibition of adenylate cyclase were characterized. Specific [3H]NMS binding to membrane preparations was rapid, saturable, and of high affinity. Saturation experiments revealed a single class of binding sites for the radioligand. Competition experiments with the muscarinic drugs pirenzepine, AF DX 116, dicyclomine and atropine revealed that the muscarinic receptors present on these cells are predominantly of a single class, subtype B (M2). In addition, agonist binding demonstrated existence of a GTP-sensitive high affinity binding state of the receptors. Coupling of these muscarinic receptors to the adenylate cyclase system was investigated using the muscarinic agonist carbachol which was able to inhibit the prostaglandin (PGE1)-stimulated activation of adenylate cyclase. The agonist carbachol did not stimulate the formation of IP3 above basal levels, which indicated that the receptors are not coupled to phosphatidylinositol metabolism. In conclusion, we show that possessing predominantly one subtype of muscarinic receptor, the Neuro-2A cells provide a useful model for the investigation of the heterogeneity of muscarinic receptors and the relationship of subtype to the coupling of different effectors.
Edwards
A
A
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston 29405.
Gillard
M
M
Merler
E
E
D000818:Animals; D001667:Binding, Competitive; D000242:Cyclic AMP / Q000378:metabolism; D015544:Inositol 1,4,5-Trisphosphate; D007295:Inositol Phosphates / Q000378:metabolism; D051379:Mice; D019832:N-Methylscopolamine; D009447:Neuroblastoma / Q000032:analysis; D010276:Parasympatholytics / Q000378:metabolism; D010277:Parasympathomimetics / Q000378:metabolism; D011869:Radioligand Assay; D011976:Receptors, Muscarinic / Q000032:analysis*; D012602:Scopolamine Derivatives / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000032:analysis*
D007295:Inositol Phosphates; D010276:Parasympatholytics; D010277:Parasympathomimetics; D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; D015544:Inositol 1,4,5-Trisphosphate; D000242:Cyclic AMP; D019832:N-Methylscopolamine